Esperion Therapeutis.Inc. diskutieren
Esperion Therapeutis.Inc.
WKN: A1W1SJ / Symbol: ESPR / Name: Esperion / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
3,28 €
-2,33 %
Esperion Therapeutics, Inc. (NASDAQ: ESPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ESPR provided by MarketBeat
Esperion Therapeutics, Inc. (NASDAQ: ESPR) had its price target lowered by analysts at Needham & Company LLC from $5.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for ESPR provided by MarketBeat
Esperion Therapeutics, Inc. (NASDAQ: ESPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ESPR provided by MarketBeat
Esperion Therapeutics, Inc. (NASDAQ: ESPR) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for ESPR provided by MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Ratings data for ESPR provided by MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for ESPR provided by MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $9.00 price target on the stock.
Ratings data for ESPR provided by MarketBeat
Neueste Beiträge
Roth_Capital in Gran Tierra Energy Inc. diskutieren